|
| | (4R,12aS)-7-(benzyloxy)-9-broMo-4-Methyl-3,4-dihydro-2H-[1,3]oxazino[3,2-d]pyrido[1,2-a]pyrazine-6,8(12H,12aH)-dione Basic information |
| Product Name: | (4R,12aS)-7-(benzyloxy)-9-broMo-4-Methyl-3,4-dihydro-2H-[1,3]oxazino[3,2-d]pyrido[1,2-a]pyrazine-6,8(12H,12aH)-dione | | Synonyms: | (4R,12aS)-7-(benzyloxy)-9-broMo-4-Methyl-3,4-dihydro-2H-[1,3]oxazino[3,2-d]pyrido[1,2-a]pyrazine-6,8(12H,12aH)-dione;2H-Pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-6,8-dione, 9-bromo-3,4,12,12a-tetrahydro-4-methyl-7-(phenylmethoxy)-, (4R,12aS)-;(4R,12aS)-9-Bromo-3,4,12,12a-tetrahydro-4-methyl-7-(phenylmethoxy)-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-6,8-dione;(4R,12AS)-7-(BENZYLOXY)-9-BROMO-4-METHYL-3,4,12,12A-TETRAHYDRO-2H-PYRIDO[1,2:4,5]PYRAZINO[2,1-B][1,3]OXAZINE-6,8-DIONE | | CAS: | 1206102-10-4 | | MF: | C19H19BrN2O4 | | MW: | 419.27 | | EINECS: | 1592732-453-0 | | Product Categories: | | | Mol File: | 1206102-10-4.mol | ![(4R,12aS)-7-(benzyloxy)-9-broMo-4-Methyl-3,4-dihydro-2H-[1,3]oxazino[3,2-d]pyrido[1,2-a]pyrazine-6,8(12H,12aH)-dione Structure](CAS/20150408/GIF/1206102-10-4.gif) |
| | (4R,12aS)-7-(benzyloxy)-9-broMo-4-Methyl-3,4-dihydro-2H-[1,3]oxazino[3,2-d]pyrido[1,2-a]pyrazine-6,8(12H,12aH)-dione Chemical Properties |
| Boiling point | 599.7±50.0 °C(Predicted) | | density | 1.57±0.1 g/cm3(Predicted) | | solubility | soluble in DCM, DMSO, Methanol | | pka | -1.86±0.70(Predicted) | | form | Solid | | color | Yellow |
| | (4R,12aS)-7-(benzyloxy)-9-broMo-4-Methyl-3,4-dihydro-2H-[1,3]oxazino[3,2-d]pyrido[1,2-a]pyrazine-6,8(12H,12aH)-dione Usage And Synthesis |
| Uses | (4R,12aS)-9-Bromo-3,4,12,12a-tetrahydro-4-methyl-7-(phenylmethoxy)-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-d2-6,8-dione is an isotope labelled intermediate of Dolutegravir (D528800), a second generation HIV-1 integrase strand transfer inhibitor. |
| | (4R,12aS)-7-(benzyloxy)-9-broMo-4-Methyl-3,4-dihydro-2H-[1,3]oxazino[3,2-d]pyrido[1,2-a]pyrazine-6,8(12H,12aH)-dione Preparation Products And Raw materials |
|
